Guardion Health Sciences Announces Financial Results for the Quarter Ended March 31, 2022
May 12, 2022 08:13 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 12, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a clinical nutrition company that offers a portfolio of science-based,...
Guardion Health Sciences to Present at the Planet MicroCap Showcase 2022
May 03, 2022 15:45 ET
|
Guardion Health Sciences, Inc.
HOUSTON, May 03, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements,...
Guardion Health Sciences Announces New Viactiv® Omega Boost Gel Bites Now Available for Purchase Via Viactiv® Shopify Store
April 11, 2022 09:17 ET
|
Guardion Health Sciences, Inc.
Consumers May Now Purchase Viactiv® Omega Boost Directly from Viactiv.com Viactiv® Omega Boost Gel Bites Provide 10x More Omega-3s Than the Leading Gummies, Without the Fishy Taste and Sugar...
Guardion Health Sciences Announces Financial Results for the Year Ended December 31, 2021
April 01, 2022 09:03 ET
|
Guardion Health Sciences, Inc.
June 2021 Acquisition of Viactiv® Brand and Business Changed Operational Focus of Company and Materially Impacted 2021 Revenues, Operations and Financial Results Viactiv® Generated Net Revenues of...
Guardion Health Sciences to Participate in Fireside Chat at the 34th Annual Roth Conference
March 11, 2022 08:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, March 11, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition, medical foods, and supplements,...
Guardion Health Sciences, Inc. Announces Closing of $11 Million Public Offering
February 23, 2022 16:15 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Feb. 23, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition,...
Guardion Health Sciences, Inc. Announces Pricing of $11 Million Public Offering
February 18, 2022 09:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Feb. 18, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported nutrition,...
Guardion Health Sciences, Inc. Announces Proposed Public Offering
February 17, 2022 09:00 ET
|
Guardion Health Sciences, Inc.
HOUSTON, TEXAS, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (NASDAQ:GHSI) (“Guardion” or the “Company”), a clinical nutrition company that develops clinically supported...
Guardion Health Sciences Launches New Viactiv® Omega BOOST™ Passion Fruit Flavored Gel Bites
February 14, 2022 08:00 ET
|
Guardion Health Sciences, Inc.
New Omega BOOST™ Gel Bites Provide 10x More Omega-3 Than Leading Gummies Individually Packaged in Blisterpacks to Ensure Freshness and Portability Omega BOOST™ is the First New Viactiv® Product...
Guardion Health Sciences Launches New Online Store for Viactiv
January 24, 2022 08:30 ET
|
Guardion Health Sciences, Inc.
HOUSTON, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (“Guardion” or the “Company”) (Nasdaq: GHSI), a clinical nutrition company that develops clinically supported nutrition,...